PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis

被引:115
|
作者
Pende, D
Bottino, C
Castriconi, R
Cantoni, C
Marcenaro, S
Rivera, P
Spaggiari, GM
Dondero, A
Carnemolla, B
Reymond, N
Mingari, MC
Lopez, M
Moretta, L
Moretta, A
机构
[1] Ist Nazl Ric Canc, I-16132 Genoa, Italy
[2] Ist Giannina Gaslini, I-16148 Genoa, Italy
[3] Univ Genoa, DIMES, I-16132 Genoa, Italy
[4] Univ Genoa, DOBIG, I-16132 Genoa, Italy
[5] Ctr Eccellenza Ric Biomed, I-16132 Genoa, Italy
[6] INSERM, U 119, Inst Biol Canc & Immunol, F-13009 Marseille, France
关键词
natural killer cells; tumors; activating receptors; cellular ligands;
D O I
10.1016/j.molimm.2004.07.028
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The capability of NK lymphocytes to kill tumor cells depends on different receptors/ligands interactions. In order to identify the cellular ligands recognized by "orphan" triggering receptors, mice were immunized with NK susceptible target cells. mAbs were selected that inhibited NK cytotoxicity and recognized two different molecules of 70 and 60-65 kDa. Tryptic digestion and mass spectra analysis of purified proteins identified these molecules as PVR and Nectin-2, respectively. PVR-Fc and Nectin-2-Fc chimeric molecules stained COS-7 cells expressing the DNAM-1 activating receptor and conversely, PVR and Nectin-2 CHO-K cell transfectants were stained by DNAM-1-Fc. Thus, both PVR and Nectin-2 represent specific ligands for DNAM-1. Importantly, the specific interaction between DNAM- I (in NK cells) and PVR or Nectin-2 (in target cells) enhanced the NK-mediated lysis of tumor cells that was downregulated by mAb-mediated masking of the receptor or its ligands. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:463 / 469
页数:7
相关论文
共 43 条
  • [1] Identification of PVR (CD155) and nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule
    Bottino, C
    Castriconi, R
    Pende, D
    Rivera, P
    Nanni, M
    Carnemolla, B
    Cantoni, C
    Grassi, J
    Marcenaro, S
    Reymond, N
    Vitale, M
    Moretta, L
    Lopez, M
    Moretta, A
    JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (04): : 557 - 567
  • [2] Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112)
    Tahara-Hanaoka, S
    Shibuya, K
    Onoda, Y
    Zhang, H
    Yamazaki, S
    Miyamoto, A
    Honda, S
    Lanier, LL
    Shibuya, A
    INTERNATIONAL IMMUNOLOGY, 2004, 16 (04) : 533 - 538
  • [3] Mast cell costimulation by CD226/CD112 (DNAM-1/Nectin-2) - A novel interface in the allergic process
    Bachelet, Ido
    Munitz, Ariel
    Mankutad, David
    Levi-Schaffer, Francesca
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (37) : 27190 - 27196
  • [4] Crystal Structure of Cell Adhesion Molecule Nectin-2/CD112 and Its Binding to Immune Receptor DNAM-1/CD226
    Liu, Jun
    Qian, Xiaomin
    Chen, Zhujun
    Xu, Xiang
    Gao, Feng
    Zhang, Shuijun
    Zhang, Rongguang
    Qi, Jianxun
    Gao, George F.
    Yan, Jinghua
    JOURNAL OF IMMUNOLOGY, 2012, 188 (11): : 5511 - 5520
  • [5] CD226/CD112(DNAM-1/NECTIN-2)对肥大细胞的协同刺激
    陈超
    刘擎
    周洋
    王东琳
    细胞与分子免疫学杂志, 2007, (12) : 1129 - 1129
  • [6] Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction
    Pende, D
    Castriconi, R
    Romagnani, P
    Spaggiari, GM
    Marcenaro, S
    Dondero, A
    Lazzeri, E
    Lasagni, L
    Martini, S
    Rivera, P
    Capobianco, A
    Moretta, L
    Moretta, A
    Bottino, C
    BLOOD, 2006, 107 (05) : 2030 - 2036
  • [7] Porcine nectin-2/CD112 expressed on the endothelial cells triggers human NK cytotoxicity by dnam-1
    Zhu, Min
    Wang, Lu
    Chen, Chao
    Wu, Ding-An
    Xu, Qin-Zi
    Zhao, Bo
    Liao, Yong-De
    Fu, Xiang-Ning
    Zhao, Shu-Hong
    Chen, Shi
    XENOTRANSPLANTATION, 2009, 16 (05) : 362 - 362
  • [8] Tumor rejection by the poliovirus receptor family ligands of the DNAM-1 (CD226) receptor
    Tahara-Hanaoka, S
    Shibuya, K
    Kai, H
    Miyamoto, A
    Morikawa, Y
    Ohkochi, N
    Honda, S
    Shibuya, A
    BLOOD, 2006, 107 (04) : 1491 - 1496
  • [9] Tumor rejection mediated by the poliovirus receptor family ligands of the DNAM-1 (CD226) receptor
    Tahara-Hanaoka, S
    Shibuya, K
    Miyamoto, A
    Honda, S
    Shibuya, A
    FASEB JOURNAL, 2005, 19 (04): : A39 - A39
  • [10] DNAM-1/Tigit/CD155/CD112 Axis Is a Novel Target of NK-Cell Therapy in Acute Myeloid Leukemia
    Kaito, Yuta
    Sugimoto, Emi
    Nakamura, Fumi
    Tsukune, Yutaka
    Sasaki, Makoto
    Yui, Shunsuke
    Yamaguchi, Hiroki
    Goyama, Susumu
    Nannya, Yasuhito
    Mitani, Kinuko
    Tamura, Hideto
    Imai, Yoichi
    BLOOD, 2022, 140 : 4514 - 4516